Dinghang Capital logo

Dinghang Capital

Asia, Jilin, China, Guangdong

Description

Dinghang Capital provides investors with professional asset management services.

Investor Profile

Dinghang Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Medical, Pharmaceutical, Biotechnology.

Stage Focus

  • Seed (50%)
  • Series B (50%)

Country Focus

  • China (100%)

Industry Focus

  • Medical
  • Pharmaceutical
  • Biotechnology
  • Health Care
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dinghang Capital frequently co-invest with?

CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Co-Investments: 1
BGI Co-Win
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
New Industry Ventures
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
Cornerstone Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
FV
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
XtalPi
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
IMO Ventures
North America, California, United States, San Mateo
Co-Investments: 1
Tiantu Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
CPE Capital
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1

What are some of recent deals done by Dinghang Capital?

META Pharmaceuticals

Shenzhen, Guangdong, China

META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases.

MedicalPharmaceutical
SeedJun 13, 2022
Amount Raised: $15,000,000
MGI Tech

Shenzhen, Guangdong, China

MGI Tech focuses on developing and promoting advanced life science tools for future healthcare.

BiotechnologyHealth CareLife ScienceMedical
Series BMay 28, 2020
Amount Raised: $1,000,000,000